HEMAFLO THERAPEUTICS

hemaflo-therapeutics-logo

HemaFlo Therapeutics, Inc. is an early stage company founded to commercialize a novel new device for the treatment of acute kidney injury and other ischemic conditions. The device is a very dilute solution of drag-reducing polymer (DRP) that is simply delivered intravenously to patients. Drag-reducing polymers have been studied in animals since the mid-1970’s and have shown dramatic benefits in disease models such as heart attack, hemorrhagic shock, diabetes, and atherosclerosis. The work h... as received little attention because the mechanism of action was unknown until just recently. HemaFlo Therapeutics has shown that drag-reducing polymers can be used to treat a very common and deadly condition that has a very attractive commercialization pathway. Acute kidney injury has no effective treatment and there are as many new cases in the US each year as for heart attacks, strokes, and cancer combined! Acute kidney injury is not widely perceived to be a serious problem because most cases occur in the hospital as a consequence of other diseases or procedures, resolve in a week or two, and the deaths are coded as heart failure (loss of regulation of electrolytes), respiratory failure (loss of regulation of fluids), or sepsis.

#SimilarOrganizations #People #Financial #Website #More

HEMAFLO THERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2012-01-01

Address:
Carlsbad, California, United States

Country:
United States

Website Url:
http://www.hemaflo.com

Total Employee:
11+

Status:
Active

Contact:
(760)607-6460

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Microsoft Exchange Online Microsoft Azure DNS GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region


Similar Organizations

anthos-therapeutics-logo

Anthos Therapeutics

Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.

Current Employees Featured

not_available_image

Dale Peterson
Dale Peterson Founder and Chief Scientific Officer @ HemaFlo Therapeutics
Founder and Chief Scientific Officer

michael-a-martino_image

Michael A. Martino
Michael A. Martino President and CEO @ HemaFlo Therapeutics
President and CEO
2015-05-01

Founder


not_available_image

Dale Peterson

Investors List

medtechinnovator_image

MedTech Innovator

MedTech Innovator investment in Grant - HemaFlo Therapeutics

Official Site Inspections

http://www.hemaflo.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 13.248.169.48
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "HemaFlo Therapeutics" on Search Engine